Concepedia

Sujal V. Deshmukh

SV

23

Publications

940

Citations

17

H-Index

2002

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The University of Texas Medical Branch at Galveston

Novartis (United States)

University of Missouri–Kansas City

United States Military Academy

Sujal V. Deshmukh is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryMolecular PharmacologyChemical BiologyNatural SciencesMedicinal ChemistryPlacental DevelopmentAromatase

Publications per year

2002–2022

23

Publications

23

Transplacental Transfer and Metabolism of Buprenorphine

Tatiana Nanovskaya, Sujal V. Deshmukh, Monica Brooks et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 159 citations

Bidirectional transfer of methadone across human placenta

Ilona Nekhayeva, Tatiana Nanovskaya, Sujal V. Deshmukh et al. · Biochemical Pharmacology · 2004 · 85 citations

Substance Abuse, Human Placenta, Gynecology +6

MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor

Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard et al. · Cancer Research · 2010 · 82 citations

Activated C-met Receptor, Cell Culture, Cancer Biology +19

Methadone metabolism by human placenta

Tatiana Nanovskaya, Sujal V. Deshmukh, Ilona Nekhayeva et al. · Biochemical Pharmacology · 2004 · 69 citations

Human Placenta, Medicine, Maternal Health +6

Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells

Kumiko Nagashima, Stuart D. Shumway, Sriram Sathyanarayanan et al. · Journal of Biological Chemistry · 2010 · 64 citations · Full text

Rows per page

1–5 of 23